drug
riboflavin 5'-phosphate sodium
Marketedupdated 5mo agoby $GKOS GLAUKOS Corp
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2Small molecule drug with a maximum clinical stage of Approval, with an approval for keratoconus.
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 17, 2028
~2.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
FDA exclusivities (1)
- Oct 17, 2028NPNP2.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that